Market Overview

Adamas Pharmaceuticals Sharply Higher Off New Outperform Rating


Adamas Pharmaceuticals Inc (NASDAQ: ADMS) shares are trading higher by $4.50 (22 percent) at $24.01 in Monday's session.

Before the open, Evercore ISI Group initiated coverage on the company with an Outperform rating and a $85.00 price target.

After a higher open, Adamas had nearly a $1.00 drop to $22.10 before continuing its move higher. The ensuing rally took the stock to $24.55, but has fallen back under $24.00.

That marks the highest level for the stock since Jan. 19, 2016, when it peaked at $25.89.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (ADMS)

View Comments and Join the Discussion!

Toys R Us Blamed For Toy Stocks' Tepid Q3 Performances

Gambling Stock Q3 Earnings Roundup: Wynn, Las Vegas Sands, And More